The invention relates to neurophysiology and in particular to apparatus and methods for stimulating nerves through the walls of blood vessels. Non-limiting embodiments include nerve stimulation apparatus, electrode structures, electrodes and related methods.
Nerve stimulation can be applied in the treatment of a range of conditions. Nerve stimulation may be applied to control muscle activity or to generate sensory signals. Nerves may be stimulated by surgically implanting electrodes in or near the nerves and driving the electrodes from an implanted or external source of electricity.
The phrenic nerves normally carry signals that cause the contractions of the diaphragm that are necessary for breathing. Various conditions can prevent appropriate signals from being delivered to the phrenic nerves. These include:
Mechanical ventilation (MV) may be used to help patients breathe. Some patients require chronic mechanical ventilation and many more patients require temporary mechanical ventilation. Mechanical ventilation can be lifesaving but has a range of significant problems and/or side effects. Mechanical ventilation:
A patient on mechanical ventilation is tied to a ventilator, and does not breathe independently. This can lead to atrophy of the diaphragm muscle (ventilator induced diaphragmatic dysfunction; VIDD) and an overall decline in well being. Muscle atrophy can occur surprisingly rapidly and can be a serious problem. In patients on mechanical ventilation, the central respiratory drive of the diaphragm is suppressed. The inactivity of the diaphragm muscle causes rapid disuse atrophy. According to a published study (Levine et al., New England Journal of Medicine, 358: 1327-1335, 2008), the diaphragm muscle could shrink by 52-57% after just 18-69 hours of mechanical ventilation and sedation. Ventilator-induced diaphragm atrophy could cause a patient to become ventilator-dependent. Patients in intensive care units (ICU) who become dependent on mechanical ventilation (MV) are at high risk of complications such as ventilator-acquired pneumonia (VAP) and nosocomial infections and are seven times more likely to die in the ICU. It has been reported that in 2008, 1.58 million ICU patients in the United States require MV every year, of which 20-30% (about 400,000 mechanically ventilated patients) have difficulty weaning from MV and are at risk of becoming ventilator-dependent.
Three methods have been used to reverse or slow down atrophy in disused diaphragm muscles by stimulating the phrenic nerves and are discussed below.
Method 1. Phrenic nerve pacing uses electrodes implanted in the chest to directly stimulate the phrenic nerves. The Mark IV Breathing Pacemaker System available from Avery Biomedical Devices, Inc. of Commack, N.Y., USA, is a diaphragmatic or phrenic nerve stimulator that has surgically implanted receivers and electrodes mated to an external transmitter by antennas worn over the implanted receivers. Implanting electrodes and other implantable components for phrenic nerve pacing requires significant surgery. The surgery is risky and complicated by the fact that phrenic nerves are thin (approximately 2 mm in diameter) and delicate. The surgery involves significant cost.
Method 2. Laproscopic diaphragm pacing developed by biomedical engineers and physician researchers at Case Western Reserve University is another technique for controlling breathing. Laproscopic diaphragm pacing involves placing electrodes at motor points of the diaphragm.
Method 3. A method using intravascularly implanted electrodes to stimulate a nerve has been developed by Joaquin Andres Hoffer and is described in U.S. patent application Ser. No. 12/524,571 (published on Feb. 11, 2010 as US2010/00336451) entitled “Transvascular Nerve Stimulation Apparatus And Methods”, which is hereby incorporated by reference.
Method 3 has advantages over Methods 1 and 2, because it does not require invasive surgery that would typically be performed under full anaesthesia. Furthermore, ICU patients are not typically eligible for Methods 1 and 2.
There remains a need for cost-effective, practical, surgically simple and minimally invasive apparatus and methods for nerve stimulation. There is also a need for apparatus and methods for facilitating patients on MV to breathe more naturally and to be weaned from MV. There is also a need for cost effective, practical apparatus and methods for installing and/or removing nerve stimulation apparatus.
This invention has a number of aspects. Aspects of the invention include: designs for intravascular electrodes; electrode structures; nerve stimulation apparatus; intravascular apparatus including electrodes and structures for introducing and supporting the electrodes; catheters equipped with electrodes; methods for nerve stimulation; and methods for measuring the location of an electrode structure within a blood vessel relative to a target nerve. While these and other aspects may be applied together, individual aspects may be applied separately as well as in other combinations and contexts. For example, electrode structures as described herein may be applied in combination with various deployment systems known in the art for various diagnostic and/or therapeutic applications.
Aspects of the invention may be applied for restoring breathing, treating conditions such as muscle atrophy, chronic pain, and other uses involving nerve stimulation. Aspects of the invention may be applied in the treatment of acute or chronic conditions. Aspects of the invention may be applied to conveniently deploy and remove electrode structures in a patient.
One aspect of the invention relates to transvascular stimulation of nerves. In transvascular stimulation, suitable arrangements of one or more electrodes are positioned in a blood vessel that passes close to a nerve to be stimulated. Electrical currents pass from the electrodes through a wall of the blood vessel to stimulate the target nerve.
One aspect of the invention relates to transvascular stimulation of nerves in the neck and chest of a human or other mammals (e.g., a pig).
Further aspects of the invention and features of example embodiments are illustrated in the appended drawings and/or described in the text of this specification and/or described in the accompanying claims.
The accompanying drawings illustrate non-limiting example embodiments of the invention.
Throughout the following description, specific details are set forth in order to provide a more thorough understanding of the invention. However, the invention may be practiced without these particulars. In other instances, well-known elements have not been shown or described in detail to avoid unnecessarily obscuring the invention. Accordingly, the specification and drawings are to be regarded in an illustrative, rather than restrictive.
Apparatus according to some embodiments provides intravascular electrode systems which include one or more electrodes supported on an elongated resiliently flexible support member. The support member may be used to introduce the electrodes into a blood vessel. As the support member is introduced into the blood vessel the support member bends to follow the path of the blood vessel. Restoring forces resulting from the resilience of the support member hold the one or more electrodes in place against the wall of the blood vessel. The electrode structure may comprise flexible electrically insulating pads that insulate electrodes from being in direct contact with blood in the main passage of the blood vessel.
In some embodiments the apparatus includes two or more electrodes at spaced-apart locations along the support member. Spacing between the electrodes may be selected to allow the electrodes to be located proximate to anatomical structures, for example nerves passing nearby the blood vessel. In an example embodiment, electrodes are spaced apart on a support structure and oriented so that an intravascular electrode system may be placed with electrodes located to stimulate a patient's left and right phrenic nerves. The electrodes may optionally have different circumferential orientations with respect to a longitudinal centerline of the support structure.
In some embodiments the support member is more flexible in one direction than in another. This can help to preserve a desired orientation of electrodes while the electrode system is being introduced into a blood vessel.
In some embodiments the electrode system comprises a catheter having one or more lumens. The catheter may provide the functionality of a central catheter of the type commonly used in intensive care units, for example. Such embodiments provide the advantage of electrodes that may be applied, for example, for stimulating nerves (e.g. for diaphragm pacing) and/or for monitoring electrical activity in the body of a patient in the same package as a central catheter that may be required in any event. In some embodiments, the catheter also serves as a support structure as described above.
Some embodiments comprise electrode structures comprising electrodes and asymmetrical electrically-insulating backing sheets. The backing sheets can electrically isolate the electrodes from blood in the lumen of a blood vessel, thereby allowing more efficient stimulation of extravascular structures such as nearby nerves. The asymmetrical arrangement of the backing sheet allows the backing sheet to be rolled into a compact configuration for insertion of the electrode structure into a blood vessel while providing a backing sheet that can provide electrical insulation for two or more electrodes. In some embodiments the backing sheet has a generally trapezoidal configuration. The backing sheet may be formed so that it tends to unroll from the rolled configuration. The backing sheet may be formed with a natural curvature similar to that of a wall of a blood vessel against which the backing sheet will be deployed. The backing sheet may be but need not be completely electrically insulating. Such a backing sheet can be advantageous as long as it provides a resistance to the flow of electricity substantially greater than the resistance that would be provided by blood in the blood vessel in the absence of the backing sheet. Such electrode structures may be applied in a wide range of intravascular applications.
Some embodiments provide electrode structures that include a retainer that holds a backing sheet in place. The retainer may comprise, for example, a formed piece of wire that extends through apertures in the backing sheet. In some embodiments the retainer comprises a pair of wire sections, which may be generally parallel, that are each woven through apertures in the backing sheet. Distal ends of the wire sections may be joined. The wire sections may be parts of a continuous wire. Distal ends of the wire sections may be bent back over the backing sheet. In some embodiments the retainer is electrically conductive and may be applied as one electrode, for example a reference electrode for electrical measurements and/or one of two or more electrodes for delivery of stimulation. The backing sheet may be rolled around the retainer for introduction into a blood vessel. Such electrode structures may be applied in a wide range of applications.
Some embodiments provide electrode structures in which a backing sheet for one or more electrodes is provided by a wall of an inflatable structure. The structure may be inflated to hold the electrodes against a wall of a blood vessel. The structure may, for example, be located on a side of a catheter or other support member. In some embodiments, inflation of the inflatable structure actuates a backing member carrying one or more electrodes to move toward engagement with a wall of a blood vessel.
Some embodiments provide intravascular electrode structures on which one or more electrodes is supported on a support member which include integrated position-measurement transducers for measuring a displacement of an electrode along a blood vessel into which the electrode is being inserted. The apparatus, including the position-measurement transducers may be intended to be disposable after a single use. Various embodiments of example position measurement transducers that can provide accurate position measurement in a suitable form factor and/or may be fabricated inexpensively are described below.
The following description describes examples of nerve stimulation apparatus and components suitable for application in nerve stimulation. In some cases the examples given are adapted for stimulation of phrenic nerves in a human or other mammals. The nerve stimulation apparatus described herein has a number of features which are particularly advantageous in combination with one another but can also be used individually, in other combinations, or in combination with the features described in US2010/00336451.
Tubular member 24 has a distal end 26, a proximal end 28, an outer wall or sheath 30 that extends from distal end 26 to proximal end 28. Tubular member 24 may comprise one or more internal lumens (not specifically indicated in
In the example embodiment, at least one lumen extends longitudinally from proximal end 28 to distal end 26. The lumens may have exit openings on wall 30 of tubular member 24. These openings may be spaced apart along the length of tubular member 24. The lumens may be used for removing blood samples, inserting medication, delivering fluids or nutrients, measuring chemical or physical parameters in blood, such as pH or temperature, and the like. For example, agents may be applied through one or more of the openings to prevent clot formation on electrode structures 12. In
Tubular member 24 may be flexible. A range of materials may be used for construction of tubular member 24, including silicone, polyurethane, or other suitable polymers, stainless steel, and the like. Tubular member 24 may have markings for length determination. In some embodiments, tubular member 24 is more flexible in one bending direction than in another bending direction. In some embodiments, different sections of tubular member 24 have different levels of flexibility. For example, the distal part of tubular member 24 may be more flexible than the proximal part of tubular member 24.
Electrode structure 12A is positioned at or near distal end 26 of tubular member 24. Electrode structure 12B is positioned at a mid-portion of tubular member 24. Electrode structures 12A, 12B are movable between a retracted position (i.e., received in tubular member 24) and a deployed position (i.e., extending out of tubular member 24). When electrode structures 12A, 12B are in a retracted position, electrode structures 12A, 12B are located inside or mostly inside tubular member 24 (
In
Each electrode structure 12 may be coupled to an elongated flexible shaft portion 14 which extends inside tubular member 24. Shaft portion 14 is not directly visible in
At equilibrium, shaft portion 14 may have a configuration that is straight or curved. Shaft portion 14 may have an initial radius of curvature greater than a radius of curvature of the left brachiocephalic vein (BCV) and superior vena cava (SVC) into which nerve stimulation apparatus 10 may be introduced. Shaft portion 14 may be resilient and tending to return to its original configuration; thus, distal end 16 of shaft portion 14 tends to spring toward the far wall of the superior vena cava (SVC) when nerve stimulation apparatus 10 is inserted in a patient from the left side of the body (e.g., from LSV into BCV and SVC). This is convenient because the right phrenic nerve typically runs alongside the far wall of the superior vena cava (SVC) at this point.
In some embodiments, shaft portion 14 is more flexible in one direction than in another direction. For example, shaft portion 14 may be oriented such that it is easier to bend downwardly than sideways. This facilitates insertion and positioning of shaft portion 14 in SVC which extends downwardly from the BCV.
In some embodiments, different parts of shaft portion 14 have different levels of flexibility. For example, the distal part of shaft portion 14 may be more flexible than the proximal part of shaft portion 14. In some embodiments, flexibility of the shaft portion may vary along the length of the shaft portion. Shaft portion 14 may be made of stainless steel or other suitable material (e.g., Nitinol, high-density plastics, elastomers etc.). In some embodiments shaft portion 14 comprises a pair of flexible stainless steel tubes that are attached together by, for example, welding.
The operation of nerve stimulation apparatus 10 is schematically shown in
In the deployed position, electrode structures 12A, 12B extend out of tubular member 24. Electrodes 20 are pressed against a wall of the blood vessel, whereas the insulating pads 42 of the electrode structures 12A, 12B prevent the electrodes 20 from being in close electrical contact with the bulk of the blood flowing through the blood vessel. The curvature of nerve stimulation apparatus 10 may conform to the curvature of the patient's left BCV and SVC. The two electrode structures 12A, 12B may be arranged roughly at 90° to one another about the longitudinal axis of nerve stimulation apparatus 10, with electrode structure 12A oriented toward the right phrenic nerve and electrode structure 12B oriented toward the left phrenic nerve.
Testing may be done to locate electrode structures 12A, 12B at desired positions relative to the left and right phrenic nerve. Methods for locating an electrode structure relative to a target nerve are described below herein (see
Once nerve stimulation apparatus 10 has been properly inserted into a patient as described above, electrodes 20 are electrically coupled to a stimulation device (e.g., a pulse generator which may be optionally located outside the body) to apply electric current to the phrenic nerves, causing the diaphragm muscle to contract. The contraction of the diaphragm muscle causes inhalation of air into the lungs. When the electric stimulation of the phrenic nerves is stopped, the diaphragm muscle relaxes and exhalation occurs. This allows the patient to breathe more naturally. Nerve stimulation apparatus 10 may be used in combination with a control unit (e.g., a bedside control unit).
Nerve stimulation apparatus 10 may be removed from the patient's body. During removal, electrode structures 12A, 12B may be first moved from a deployed configuration (
Shaft portion 14 may take a number of different configurations. In the embodiment shown in
In the embodiment shown in
Nerve stimulation apparatus 10H may be coupled to an introducer 38H and a hub 40H. This may be done during use to facilitate entry of the nerve stimulation apparatus into a patient's blood vessel. It should be noted that other types of introducers and/or hubs different from the ones shown in
Tubular member 24H is partially received in tubular member 36H of introducer 38H. When nerve stimulation apparatus 10H is applied to a patient, hub 40H and the wing portion of introducer 38H stay outside of the patient. Introducer 38H and/or hub 40H may comprise holes for suture. In their deployed configuration, electrode structures 12AH and 12BH have a transverse dimension that is greater than the transverse dimension of tubular member 24H. Apparatus 10H comprises a thermistor 64H or other temperature sensor.
Tubular member 24H may comprise a multi-lumen catheter.
It is not mandatory that pad 42P have an extremely high electrical resistance. It is sufficient if pad 42P has a resistance to the flow of electricity through pad 42P that is significantly greater than that presented by the blood in blood vessel V. Blood typically has a resistivity of about 120 to 190 Ωcm. In example embodiments, the blood in a blood vessel may provide an electrical resistance between closely-spaced electrical contacts that is inversely proportional to the dimensions of the lumen of the blood vessel. In large blood vessels the longitudinal electrical resistance between reasonable closely-spaced contacts can be a few tens of ohms for example. Pad 42P preferably provides an electrical resistance of at least a few hundred ohms, preferably a few kilo ohms or more to the flow of electrical current through the thickness of pad 42P. Pad 42P could have electrically conductive members such as leads and the like embedded within it or electrically-conductive electrode or other features on its inner surface and still be considered to be ‘insulating’.
For example, electrode 20P may be supported on pad 42P. Pad 42P can be rolled up and retracted into the tubular member to facilitate insertion or retrieval of electrode structure 12P within a blood vessel. When electrode structure 12P is deployed, pad 42P can spring open to take a shape that has a curvature that generally conforms to the wall of a blood vessel. This helps to bring electrode 20P which is on a side of pad 42P to be in close proximity of the blood vessel wall. Blood flow in the blood vessel may also assist in deploying electrode structure 12P and pressing pad 42P against the walls of a blood vessel. It should be noted that electrode structure 20P does not need to be fixed or fastened to the blood vessel wall, but rather can float inside the blood vessel against the wall.
In the embodiment of
In the illustrated embodiment, electrode 20P is exposed on one side (e.g., the convex side, i.e., the side facing the blood vessel wall) of pad 42P. Pad 42P may, for example, comprise a reinforced silicone material. In one embodiment, pad 42P is a pad of Dacron-mesh-reinforced silicone. This material can be rolled up, has shape memory so that it tends to open up, and is resiliently flexible so that it can conform to the wall of a blood vessel. Blood flow in the blood vessel may also assist in deploying electrode structure 12P and supporting electrode structure 12P against the walls of a blood vessel.
The material of electrode 20Q is preferably relatively thin so that it does not make the electrode structure too stiff. For example, the electrode material may comprise metal ribbons 48Q that are 0.5 to 1 mm wide, or less than 0.5 mm wide. In other embodiments the electrodes may comprise areas of conductive polymer printed on or contained in the insulating material of the electrode structure.
Generally, the delivery of electrical stimulation to a target nerve is enhanced by:
Experiments conducted by the inventors have shown that it is possible to achieve a similar level of stimulation of a target nerve using insulated electrodes by applying only one third of the electric current as compared to using uninsulated electrodes. The reduced electric current can result in less damage to tissues within a patient as well as a lower risk of unintended stimulation. Additionally, selectivity for a target nerve is improved. Low current and high selectivity for a target nerve is advantageous because it avoids activating non-target nerves which may be close by. For example, it is known that the vagus nerve is typically 2-3 cm medial with respect to the phrenic nerves in humans.
Where shaft portion 14P comprises stainless steel tube(s), the wire 44P may, for example, be welded or otherwise attached to the stainless steel tube(s). Wire 44P may comprise a loop of 0.010 inch stainless steel (for example Elgiloy™). The wire of the loop may pass through apertures 46P in the insulating pad 42P on which electrode(s) 20P are supported as shown in
As shown in
The
By making a set of such measurements, one can obtain a function indicating how the amount of electric current required to stimulate nerve N varies in relation to the position of electrode structure 12 along blood vessel V.
One aspect of the invention relates to sensors for sensing and/or monitoring the position of an electrode structure 12 inserted into a blood vessel and associated methods. The sensor may be optionally disposable. The sensor may be placed outside of the patient's body. The sensor may be fixed to the reference frame of the patient's body. As an electrode structure 12 is advanced and/or rotated in a blood vessel by a therapist, the sensor acquires positional data and can also relay data to a control unit where electrode position is monitored simultaneously with stimulation parameters and results of stimulation. The control unit calculates the best placement of electrodes 20 and can store this information or provide feedback to the therapist in real time or at later times.
A nerve stimulation system according to an embodiment of the present invention may comprise the following: an intravascular nerve stimulation apparatus having flexible tubular member(s) that can be inserted, advanced, and/or rotated in a blood vessel; one or more sensors that track the position of the intravascular electrodes; and a control unit that acquires position data and relays it to the therapist and/or stores it for later use. Typically, the sensor is coupled to a proximal part of a shaft portion of the nerve stimulation apparatus. The sensor may be placed outside of the body.
In some embodiments, the sensor is a pressure-sensitive variable resistance potentiometer sensor. Such a sensor is suitable for monitoring the position (depth) of an intravascular electrode inside a blood vessel. The sensor supplies a voltage output signal that is approximately linearly proportional to the position of the electrode.
The length of the active region of the potentiometer 81 limits the distance over which the depth of the electrode 20 can be tracked. In some embodiments, a commercially available flexible potentiometer may be used with a 6 cm long active region which is sufficient to monitor the movement of an electrode in the vicinity of its target phrenic nerve. However, potentiometers of any desired length may be manufactured for this purpose. If shaft portion 14 has a circular cross-section and bead 82 is spherical and coaxial the shaft portion 14, the shaft portion 14 can be rotated while maintaining contact with the potentiometer 81 to obtain the angular positions of the shaft portion 14 and electrode 20.
In some embodiments, sensor 80 is integrated with the hub of a nerve stimulation apparatus. An example sensors 80G is shown in
One or more angle sensors may be used with the apparatus described herein.
Shroud 302 may be connected to and/or supported by a pair of flexible members such as rods or tubes 308 which run inside tubular member 306 when shroud 302 is not deployed. The flexible members may be resiliently flexible. Rods or tubes 308 may be made of stainless steel, Nitinol, or some other suitable material, for example. The distal ends of rods or tubes 308 may be anchored or fixed to tubular member 306 at anchor positions 310. In alternative embodiments, distal ends of rods or tubes 308 may move freely to some extent along the tubular member 306. Tubular member 306 comprises side openings 312.
Shroud 302 can be manipulated from outside the body to move between a collapsed configuration and an expanded configuration. When a user pushes the proximal ends of rods or tubes 308 towards the distal ends, portions of rods or tubes 308 along side openings 312 bulge out and extend out of side openings 312 of tubular member 306. This in turn stretches shroud 302 to open to an expanded configuration. When shroud 302 is expanded, it forms a petal-like backing member for electrodes 304. Shroud 304 may help to position electrodes 304 against the blood vessel wall. The electrically insulating shroud also functions as an electrically insulating backing sheet which helps to insulate electrodes 304 from the blood flowing in the lumen of the blood vessel.
To return shroud 302 into tubular member 306, the force applied to rods or tubes 308 is released. Rods or tubes 308 are returned to a straight configuration and retrieved into tubular member 306. This in turn brings shroud 302 into a collapsed configuration inside tubular member 306.
The “cobra” design shown in
Electrodes 304 could be located on tubular member 306. Instead of or in addition to electrodes 304 on tubular member 306, electrodes 304 could be on shroud 302. Where flexible members 308 are electrically conductive, portions of flexible member 308 may be exposed to provide electrodes.
The applications of the apparatus and methods described herein are not limited to phrenic nerves. The apparatus and methods described herein may be applied to provide surgically simple, low risk solutions for stimulating a wide range of peripheral or cranial nerves. For example, the methods and apparatus may be applied to stimulate the obturator nerve in the hip/groin area or the trigeminal nerve in the head.
The apparatus and methods may be applied to treatment of a wide variety of disorders such as pain of peripheral or craniofacial origin, sensory deficits, paralysis or paresis of central origin, autonomic disorders, and generally any medical condition that can be treated or alleviated using neuromodulation by electrical stimulation of a nerve that is in close proximity to a blood vessel into which a nerve stimulation apparatus can be deployed.
Various elements of the invention may be used alone, in combination, or in a variety of arrangements not specifically discussed in the embodiments described in the foregoing. For example, elements described in one embodiment may be combined with elements described in other embodiments to yield further example embodiments.
The scope of the invention should not be limited by the embodiments set forth in the examples, but should be given the broadest interpretation consistent with the description as a whole.
This application claims priority from U.S. Application No. 61/606,899 filed 5 Mar. 2012. For purposes of the United States, this application claims the benefit under 35 U.S.C. § 119 of U.S. Application No. 61/606,899 filed 5 Mar. 2012 and entitled TRANSVASCULAR NERVE STIMULATION APPARATUS AND METHODS which is hereby incorporated herein by reference for all purposes.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CA2013/050159 | 3/4/2013 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2013/131187 | 9/12/2013 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1693734 | Waggoner | Dec 1928 | A |
2532788 | Sarnoff | Dec 1950 | A |
2664880 | Wales, Jr. | Jan 1954 | A |
3348548 | Chardack | Oct 1967 | A |
3470876 | John | Oct 1969 | A |
3769984 | Muench | Nov 1973 | A |
3804098 | Friedman | Apr 1974 | A |
3817241 | Grausz | Jun 1974 | A |
3835864 | Rasor et al. | Sep 1974 | A |
3847157 | Caillouette et al. | Nov 1974 | A |
3851641 | Toole et al. | Dec 1974 | A |
3896373 | Zelby | Jul 1975 | A |
3938502 | Bom | Feb 1976 | A |
3983881 | Wickham | Oct 1976 | A |
4054881 | Raab | Oct 1977 | A |
4072146 | Howes | Feb 1978 | A |
4114601 | Abels | Sep 1978 | A |
4173228 | Childress et al. | Nov 1979 | A |
4249539 | Mezrich et al. | Feb 1981 | A |
4317078 | Weed et al. | Feb 1982 | A |
4380237 | Newbower | Apr 1983 | A |
4407294 | Vilkomerson | Oct 1983 | A |
4416289 | Bresler | Nov 1983 | A |
4431005 | McCormick | Feb 1984 | A |
4431006 | Trimmer et al. | Feb 1984 | A |
4445501 | Bresler | May 1984 | A |
RE31873 | Howes | Apr 1985 | E |
4573481 | Bullara | Mar 1986 | A |
4586923 | Gould et al. | May 1986 | A |
4587975 | Salo et al. | May 1986 | A |
4643201 | Stokes | Feb 1987 | A |
4674518 | Salo | Jun 1987 | A |
4681117 | Brodman et al. | Jul 1987 | A |
4683890 | Hewson | Aug 1987 | A |
4697595 | Breyer et al. | Oct 1987 | A |
4706681 | Breyer et al. | Nov 1987 | A |
4771788 | Millar | Sep 1988 | A |
4819662 | Heil, Jr. et al. | Apr 1989 | A |
4827935 | Geddes et al. | May 1989 | A |
4830008 | Meer | May 1989 | A |
4840182 | Carlson | Jun 1989 | A |
4852580 | Wood | Aug 1989 | A |
4860769 | Fogarty et al. | Aug 1989 | A |
4905698 | Strohl, Jr. et al. | Mar 1990 | A |
4911174 | Pederson et al. | Mar 1990 | A |
4934049 | Kiekhafer et al. | Jun 1990 | A |
4944088 | Doan et al. | Jul 1990 | A |
4951682 | Petre | Aug 1990 | A |
4957110 | Vogel et al. | Sep 1990 | A |
4989617 | Memberg et al. | Feb 1991 | A |
5005587 | Scott | Apr 1991 | A |
5036848 | Hewson | Aug 1991 | A |
5042143 | Holleman et al. | Aug 1991 | A |
5056519 | Vince | Oct 1991 | A |
5115818 | Holleman et al. | May 1992 | A |
5146918 | Kallok et al. | Sep 1992 | A |
5170802 | Mehra | Dec 1992 | A |
5184621 | Vogel et al. | Feb 1993 | A |
5224491 | Mehra | Jul 1993 | A |
5243995 | Maier | Sep 1993 | A |
5265604 | Vince | Nov 1993 | A |
5267569 | Lienhard | Dec 1993 | A |
5314463 | Camps et al. | May 1994 | A |
5316009 | Yamada | May 1994 | A |
5324322 | Grill, Jr. et al. | Jun 1994 | A |
5330522 | Kreyenhagen | Jul 1994 | A |
5345936 | Pomeranz et al. | Sep 1994 | A |
5383923 | Webster, Jr. | Jan 1995 | A |
5411025 | Webster, Jr. | May 1995 | A |
5417208 | Winkler | May 1995 | A |
5451206 | Young | Sep 1995 | A |
5456254 | Pietroski et al. | Oct 1995 | A |
5465717 | Imran et al. | Nov 1995 | A |
5476498 | Ayers | Dec 1995 | A |
5486159 | Mahurkar | Jan 1996 | A |
5507725 | Savage et al. | Apr 1996 | A |
5524632 | Stein et al. | Jun 1996 | A |
5527358 | Mehmanesh et al. | Jun 1996 | A |
5531686 | Lundquist et al. | Jul 1996 | A |
5549655 | Erickson | Aug 1996 | A |
5555618 | Winkler | Sep 1996 | A |
5567724 | Kelleher et al. | Oct 1996 | A |
5584873 | Shoberg et al. | Dec 1996 | A |
5604231 | Smith et al. | Feb 1997 | A |
5665103 | Lafontaine et al. | Sep 1997 | A |
5678535 | Dimarco | Oct 1997 | A |
5683370 | Luther et al. | Nov 1997 | A |
5709853 | Iino et al. | Jan 1998 | A |
5716392 | Bourgeois et al. | Feb 1998 | A |
5733255 | Dinh et al. | Mar 1998 | A |
5755765 | Hyde et al. | May 1998 | A |
5776111 | Tesio | Jul 1998 | A |
5779732 | Amundson | Jul 1998 | A |
5782828 | Chen et al. | Jul 1998 | A |
5785706 | Bednarek | Jul 1998 | A |
5788681 | Weaver et al. | Aug 1998 | A |
5813399 | Isaza et al. | Sep 1998 | A |
5814086 | Hirschberg et al. | Sep 1998 | A |
RE35924 | Winkler | Oct 1998 | E |
5824027 | Hoffer et al. | Oct 1998 | A |
5827192 | Gopakumaran et al. | Oct 1998 | A |
5916163 | Panescu et al. | Jun 1999 | A |
5944022 | Nardella et al. | Aug 1999 | A |
5954761 | Machek et al. | Sep 1999 | A |
5967978 | Littmann et al. | Oct 1999 | A |
5971933 | Gopakumaran et al. | Oct 1999 | A |
5983126 | Wittkampf | Nov 1999 | A |
6006134 | Hill et al. | Dec 1999 | A |
6024702 | Iversen | Feb 2000 | A |
6096728 | Collins et al. | Aug 2000 | A |
6120476 | Fung et al. | Sep 2000 | A |
6123699 | Webster, Jr. | Sep 2000 | A |
6126649 | Vantassel et al. | Oct 2000 | A |
6136021 | Tockman et al. | Oct 2000 | A |
6157862 | Brownlee et al. | Dec 2000 | A |
6161029 | Spreigl et al. | Dec 2000 | A |
6166048 | Bencherif | Dec 2000 | A |
6171277 | Ponzi | Jan 2001 | B1 |
6183463 | Webster, Jr. | Feb 2001 | B1 |
6198970 | Freed et al. | Mar 2001 | B1 |
6198974 | Webster, Jr. | Mar 2001 | B1 |
6201994 | Warman et al. | Mar 2001 | B1 |
6208881 | Champeau | Mar 2001 | B1 |
6210339 | Kiepen et al. | Apr 2001 | B1 |
6212435 | Lattner et al. | Apr 2001 | B1 |
6216045 | Black et al. | Apr 2001 | B1 |
6236892 | Feler | May 2001 | B1 |
6240320 | Spehr et al. | May 2001 | B1 |
6251126 | Ottenhoff et al. | Jun 2001 | B1 |
6269269 | Ottenhoff et al. | Jul 2001 | B1 |
6292695 | Webster, Jr. et al. | Sep 2001 | B1 |
6295475 | Morgan | Sep 2001 | B1 |
6360740 | Ward et al. | Mar 2002 | B1 |
6397108 | Camps et al. | May 2002 | B1 |
6400976 | Champeau | Jun 2002 | B1 |
6415183 | Scheiner et al. | Jul 2002 | B1 |
6415187 | Kuzma et al. | Jul 2002 | B1 |
6438427 | Rexhausen et al. | Aug 2002 | B1 |
6445953 | Bulkes et al. | Sep 2002 | B1 |
6449507 | Hill et al. | Sep 2002 | B1 |
6463327 | Lurie et al. | Oct 2002 | B1 |
6493590 | Wessman et al. | Dec 2002 | B1 |
6508802 | Rosengart et al. | Jan 2003 | B1 |
6526321 | Spehr | Feb 2003 | B1 |
6569114 | Ponzi et al. | May 2003 | B2 |
6584362 | Scheiner et al. | Jun 2003 | B1 |
6585718 | Hayzelden et al. | Jul 2003 | B2 |
6587726 | Lurie et al. | Jul 2003 | B2 |
6602242 | Fung et al. | Aug 2003 | B1 |
6610713 | Tracey | Aug 2003 | B2 |
6630611 | Malowaniec | Oct 2003 | B1 |
6643552 | Edell et al. | Nov 2003 | B2 |
6651652 | Ward | Nov 2003 | B1 |
6682526 | Jones et al. | Jan 2004 | B1 |
6702780 | Gilboa et al. | Mar 2004 | B1 |
6718208 | Hill et al. | Apr 2004 | B2 |
6721603 | Zabara et al. | Apr 2004 | B2 |
6757970 | Kuzma et al. | Jul 2004 | B1 |
6778854 | Puskas | Aug 2004 | B2 |
6779257 | Kiepen et al. | Aug 2004 | B2 |
6844713 | Steber et al. | Jan 2005 | B2 |
RE38705 | Hill et al. | Feb 2005 | E |
6881211 | Schweikert et al. | Apr 2005 | B2 |
6885888 | Rezai | Apr 2005 | B2 |
6907285 | Denker et al. | Jun 2005 | B2 |
6934583 | Weinberg et al. | Aug 2005 | B2 |
6981314 | Black et al. | Jan 2006 | B2 |
6999820 | Jordan | Feb 2006 | B2 |
7018374 | Schon et al. | Mar 2006 | B2 |
7047627 | Black et al. | May 2006 | B2 |
7071194 | Teng | Jul 2006 | B2 |
7072720 | Puskas | Jul 2006 | B2 |
7077823 | McDaniel | Jul 2006 | B2 |
7082331 | Park et al. | Jul 2006 | B1 |
7130700 | Gardeski et al. | Oct 2006 | B2 |
7142903 | Rodriguez et al. | Nov 2006 | B2 |
7149585 | Wessman et al. | Dec 2006 | B2 |
7155278 | King et al. | Dec 2006 | B2 |
7168429 | Matthews et al. | Jan 2007 | B2 |
7184829 | Hill et al. | Feb 2007 | B2 |
7206636 | Turcott | Apr 2007 | B1 |
7212867 | Van Venrooij et al. | May 2007 | B2 |
7225016 | Koh | May 2007 | B1 |
7225019 | Jahns et al. | May 2007 | B2 |
7229429 | Martin et al. | Jun 2007 | B2 |
7231260 | Wallace et al. | Jun 2007 | B2 |
7235070 | Vanney | Jun 2007 | B2 |
7269459 | Koh | Sep 2007 | B1 |
7277757 | Casavant et al. | Oct 2007 | B2 |
7283875 | Larsson | Oct 2007 | B2 |
7340302 | Falkenberg et al. | Mar 2008 | B1 |
7363085 | Benser et al. | Apr 2008 | B1 |
7363086 | Koh et al. | Apr 2008 | B1 |
7371220 | Koh et al. | May 2008 | B1 |
7416552 | Paul et al. | Aug 2008 | B2 |
7421296 | Benser et al. | Sep 2008 | B1 |
7454244 | Kassab et al. | Nov 2008 | B2 |
7519425 | Benser et al. | Apr 2009 | B2 |
7519426 | Koh et al. | Apr 2009 | B1 |
7522953 | Gharib et al. | Apr 2009 | B2 |
7553305 | Honebrink et al. | Jun 2009 | B2 |
7555349 | Wessman et al. | Jun 2009 | B2 |
7569029 | Clark | Aug 2009 | B2 |
7591265 | Lee et al. | Sep 2009 | B2 |
7593760 | Rodriguez et al. | Sep 2009 | B2 |
7613524 | Jordan | Nov 2009 | B2 |
7636600 | Koh | Dec 2009 | B1 |
7670284 | Padget et al. | Mar 2010 | B2 |
7672728 | Libbus et al. | Mar 2010 | B2 |
7672729 | Koh et al. | Mar 2010 | B2 |
7676275 | Farazi et al. | Mar 2010 | B1 |
7676910 | Kiepen et al. | Mar 2010 | B2 |
7697984 | Hill et al. | Apr 2010 | B2 |
7747323 | Libbus et al. | Jun 2010 | B2 |
7771388 | Olsen et al. | Aug 2010 | B2 |
7783362 | Whitehurst et al. | Aug 2010 | B2 |
7794407 | Rothenberg | Sep 2010 | B2 |
7797050 | Libbus et al. | Sep 2010 | B2 |
7813805 | Farazi | Oct 2010 | B1 |
7819883 | Westlund et al. | Oct 2010 | B2 |
7840270 | Ignagni et al. | Nov 2010 | B2 |
7853302 | Rodriguez et al. | Dec 2010 | B2 |
7869865 | Govari et al. | Jan 2011 | B2 |
7891085 | Kuzma et al. | Feb 2011 | B1 |
7925352 | Stack et al. | Apr 2011 | B2 |
7949409 | Bly et al. | May 2011 | B2 |
7949412 | Harrison et al. | May 2011 | B1 |
7962215 | Ignagni et al. | Jun 2011 | B2 |
7970475 | Tehrani et al. | Jun 2011 | B2 |
7972323 | Bencini et al. | Jul 2011 | B1 |
7974693 | Ben-David et al. | Jul 2011 | B2 |
7974705 | Zdeblick et al. | Jul 2011 | B2 |
7979128 | Tehrani et al. | Jul 2011 | B2 |
7994655 | Bauer et al. | Aug 2011 | B2 |
8000765 | Rodriguez et al. | Aug 2011 | B2 |
8019439 | Kuzma et al. | Sep 2011 | B2 |
8021327 | Selkee | Sep 2011 | B2 |
8036750 | Caparso et al. | Oct 2011 | B2 |
8050765 | Lee et al. | Nov 2011 | B2 |
8052607 | Byrd | Nov 2011 | B2 |
8104470 | Lee et al. | Jan 2012 | B2 |
8116872 | Tehrani et al. | Feb 2012 | B2 |
8121692 | Haefner et al. | Feb 2012 | B2 |
8135471 | Zhang et al. | Mar 2012 | B2 |
8140164 | Tehrani et al. | Mar 2012 | B2 |
8147486 | Honour et al. | Apr 2012 | B2 |
8160701 | Zhao et al. | Apr 2012 | B2 |
8160711 | Tehrani et al. | Apr 2012 | B2 |
8195297 | Penner | Jun 2012 | B2 |
8200336 | Tehrani et al. | Jun 2012 | B2 |
8206343 | Racz | Jun 2012 | B2 |
8224456 | Daglow et al. | Jul 2012 | B2 |
8233987 | Gelfand et al. | Jul 2012 | B2 |
8233993 | Jordan | Jul 2012 | B2 |
8239037 | Glenn et al. | Aug 2012 | B2 |
8244358 | Tehrani et al. | Aug 2012 | B2 |
8244359 | Gelfand et al. | Aug 2012 | B2 |
8244378 | Bly et al. | Aug 2012 | B2 |
8255056 | Tehrani | Aug 2012 | B2 |
8256419 | Sinderby et al. | Sep 2012 | B2 |
8265736 | Sathaye et al. | Sep 2012 | B2 |
8265759 | Tehrani et al. | Sep 2012 | B2 |
8275440 | Rodriguez et al. | Sep 2012 | B2 |
8280513 | Tehrani et al. | Oct 2012 | B2 |
8315713 | Burnes et al. | Nov 2012 | B2 |
8321808 | Goetz et al. | Nov 2012 | B2 |
8335567 | Tehrani et al. | Dec 2012 | B2 |
8340783 | Sommer et al. | Dec 2012 | B2 |
8348941 | Tehrani | Jan 2013 | B2 |
8369954 | Stack et al. | Feb 2013 | B2 |
8374704 | Desai et al. | Feb 2013 | B2 |
8388541 | Messerly et al. | Mar 2013 | B2 |
8388546 | Rothenberg | Mar 2013 | B2 |
8391956 | Zellers et al. | Mar 2013 | B2 |
8401640 | Zhao et al. | Mar 2013 | B2 |
8401651 | Caparso et al. | Mar 2013 | B2 |
8406883 | Barker | Mar 2013 | B1 |
8406885 | Ignagni et al. | Mar 2013 | B2 |
8412331 | Tehrani et al. | Apr 2013 | B2 |
8412350 | Bly | Apr 2013 | B2 |
8428711 | Lin et al. | Apr 2013 | B2 |
8428726 | Ignagni et al. | Apr 2013 | B2 |
8428730 | Stack et al. | Apr 2013 | B2 |
8433412 | Westlund et al. | Apr 2013 | B1 |
8442638 | Libbus et al. | May 2013 | B2 |
8457764 | Ramachandran et al. | Jun 2013 | B2 |
8467876 | Tehrani | Jun 2013 | B2 |
8473068 | Farazi | Jun 2013 | B2 |
8478412 | Ignagni et al. | Jul 2013 | B2 |
8478413 | Karamanoglu et al. | Jul 2013 | B2 |
8478426 | Barker | Jul 2013 | B2 |
8483834 | Lee et al. | Jul 2013 | B2 |
8504158 | Karamanoglu et al. | Aug 2013 | B2 |
8504161 | Kornet et al. | Aug 2013 | B1 |
8509901 | Tehrani | Aug 2013 | B2 |
8509902 | Cho et al. | Aug 2013 | B2 |
8509919 | Yoo et al. | Aug 2013 | B2 |
8512256 | Rothenberg | Aug 2013 | B2 |
8522779 | Lee et al. | Sep 2013 | B2 |
8527036 | Jalde et al. | Sep 2013 | B2 |
8532793 | Morris et al. | Sep 2013 | B2 |
8554323 | Haefner et al. | Oct 2013 | B2 |
8560072 | Caparso et al. | Oct 2013 | B2 |
8560086 | Just et al. | Oct 2013 | B2 |
8571662 | Hoffer | Oct 2013 | B2 |
8571685 | Daglow et al. | Oct 2013 | B2 |
8615297 | Sathaye et al. | Dec 2013 | B2 |
8617228 | Wittenberger et al. | Dec 2013 | B2 |
8620412 | Griffiths et al. | Dec 2013 | B2 |
8620450 | Tockman et al. | Dec 2013 | B2 |
8626292 | McCabe et al. | Jan 2014 | B2 |
8630707 | Zhao et al. | Jan 2014 | B2 |
8644939 | Wilson et al. | Feb 2014 | B2 |
8644952 | Desai et al. | Feb 2014 | B2 |
8646172 | Kuzma et al. | Feb 2014 | B2 |
8650747 | Kuzma et al. | Feb 2014 | B2 |
8676323 | Ignagni et al. | Mar 2014 | B2 |
8676344 | Desai et al. | Mar 2014 | B2 |
8694123 | Wahlstrand et al. | Apr 2014 | B2 |
8696656 | Abboud et al. | Apr 2014 | B2 |
8706223 | Zhou et al. | Apr 2014 | B2 |
8706235 | Karamanoglu et al. | Apr 2014 | B2 |
8706236 | Ignagni et al. | Apr 2014 | B2 |
8718763 | Zhou et al. | May 2014 | B2 |
8725259 | Kornet et al. | May 2014 | B2 |
8738154 | Zdeblick et al. | May 2014 | B2 |
8755889 | Scheiner | Jun 2014 | B2 |
8774907 | Rothenberg | Jul 2014 | B2 |
8781578 | McCabe et al. | Jul 2014 | B2 |
8781582 | Ziegler et al. | Jul 2014 | B2 |
8781583 | Cornelussen et al. | Jul 2014 | B2 |
8801693 | He et al. | Aug 2014 | B2 |
8805511 | Karamanoglu et al. | Aug 2014 | B2 |
8838245 | Lin et al. | Sep 2014 | B2 |
8858455 | Rothenberg | Oct 2014 | B2 |
8863742 | Blomquist et al. | Oct 2014 | B2 |
8886277 | Kim et al. | Nov 2014 | B2 |
8897879 | Karamanoglu et al. | Nov 2014 | B2 |
8903507 | Desai et al. | Dec 2014 | B2 |
8903509 | Tockman et al. | Dec 2014 | B2 |
8909341 | Gelfand et al. | Dec 2014 | B2 |
8914113 | Zhang et al. | Dec 2014 | B2 |
8918169 | Kassab et al. | Dec 2014 | B2 |
8918987 | Kuzma et al. | Dec 2014 | B2 |
8923971 | Haefner et al. | Dec 2014 | B2 |
8942823 | Desai et al. | Jan 2015 | B2 |
8942824 | Yoo et al. | Jan 2015 | B2 |
8948884 | Ramachandran et al. | Feb 2015 | B2 |
8968299 | Kauphusman et al. | Mar 2015 | B2 |
8972015 | Stack et al. | Mar 2015 | B2 |
8983602 | Sathaye et al. | Mar 2015 | B2 |
9008775 | Sathaye et al. | Apr 2015 | B2 |
9026231 | Hoffer | May 2015 | B2 |
9037264 | Just et al. | May 2015 | B2 |
9042981 | Yoo et al. | May 2015 | B2 |
9072864 | Putz | Jul 2015 | B2 |
9072899 | Nickloes | Jul 2015 | B1 |
9108058 | Hoffer | Aug 2015 | B2 |
9108059 | Hoffer | Aug 2015 | B2 |
9125578 | Grunwald | Sep 2015 | B2 |
9138580 | Ignagni et al. | Sep 2015 | B2 |
9138585 | Saha et al. | Sep 2015 | B2 |
9149642 | McCabe et al. | Oct 2015 | B2 |
9168377 | Hoffer | Oct 2015 | B2 |
9205258 | Simon et al. | Dec 2015 | B2 |
9216291 | Lee et al. | Dec 2015 | B2 |
9220898 | Hoffer | Dec 2015 | B2 |
9226688 | Jacobsen et al. | Jan 2016 | B2 |
9226689 | Jacobsen et al. | Jan 2016 | B2 |
9242088 | Thakkar et al. | Jan 2016 | B2 |
9259573 | Tehrani et al. | Feb 2016 | B2 |
9295846 | Westlund et al. | Mar 2016 | B2 |
9314618 | Imran et al. | Apr 2016 | B2 |
9333363 | Hoffer et al. | May 2016 | B2 |
9345422 | Rothenberg | May 2016 | B2 |
9370657 | Tehrani et al. | Jun 2016 | B2 |
9398931 | Wittenberger et al. | Jul 2016 | B2 |
9415188 | He et al. | Aug 2016 | B2 |
9427566 | Reed et al. | Aug 2016 | B2 |
9427588 | Sathaye et al. | Aug 2016 | B2 |
9474894 | Mercanzini et al. | Oct 2016 | B2 |
9485873 | Shah et al. | Nov 2016 | B2 |
9498625 | Bauer et al. | Nov 2016 | B2 |
9498631 | Demmer et al. | Nov 2016 | B2 |
9504837 | Demmer et al. | Nov 2016 | B2 |
9532724 | Grunwald et al. | Jan 2017 | B2 |
9533160 | Brooke et al. | Jan 2017 | B2 |
9539429 | Brooke et al. | Jan 2017 | B2 |
9545511 | Thakkar et al. | Jan 2017 | B2 |
9561369 | Burnes et al. | Feb 2017 | B2 |
9566436 | Hoffer et al. | Feb 2017 | B2 |
9572982 | Burnes et al. | Feb 2017 | B2 |
9597509 | Hoffer et al. | Mar 2017 | B2 |
9615759 | Hurezan et al. | Apr 2017 | B2 |
9623252 | Sathaye et al. | Apr 2017 | B2 |
9662494 | Young et al. | May 2017 | B2 |
9682235 | O'Mahony et al. | Jun 2017 | B1 |
9694185 | Bauer | Jul 2017 | B2 |
9717899 | Kuzma et al. | Aug 2017 | B2 |
9724018 | Cho et al. | Aug 2017 | B2 |
9744351 | Gelfand et al. | Aug 2017 | B1 |
9776005 | Meyyappan et al. | Oct 2017 | B2 |
9861817 | Cho et al. | Jan 2018 | B2 |
9872989 | Jung et al. | Jan 2018 | B2 |
9884178 | Bouton et al. | Feb 2018 | B2 |
9884179 | Bouton et al. | Feb 2018 | B2 |
9919149 | Imran et al. | Mar 2018 | B2 |
9931504 | Thakkar et al. | Apr 2018 | B2 |
9950167 | Hoffer et al. | Apr 2018 | B2 |
9956396 | Young et al. | May 2018 | B2 |
9968785 | Hoffer et al. | May 2018 | B2 |
9968786 | Bauer et al. | May 2018 | B2 |
20010052345 | Niazi | Dec 2001 | A1 |
20020026228 | Schauerte | Feb 2002 | A1 |
20020056454 | Samzelius | May 2002 | A1 |
20020065544 | Smits et al. | May 2002 | A1 |
20020087156 | Maguire et al. | Jul 2002 | A1 |
20020128546 | Silver | Sep 2002 | A1 |
20020188325 | Hill et al. | Dec 2002 | A1 |
20030078623 | Weinberg et al. | Apr 2003 | A1 |
20030195571 | Burnes et al. | Oct 2003 | A1 |
20040003813 | Banner et al. | Jan 2004 | A1 |
20040010303 | Bolea et al. | Jan 2004 | A1 |
20040030362 | Hill et al. | Feb 2004 | A1 |
20040044377 | Larsson et al. | Mar 2004 | A1 |
20040064069 | Reynolds et al. | Apr 2004 | A1 |
20040077936 | Larsson et al. | Apr 2004 | A1 |
20040088015 | Casavant et al. | May 2004 | A1 |
20040111139 | McCreery | Jun 2004 | A1 |
20040186543 | King et al. | Sep 2004 | A1 |
20040210261 | King et al. | Oct 2004 | A1 |
20050004565 | Vanney | Jan 2005 | A1 |
20050013879 | Lin et al. | Jan 2005 | A1 |
20050021102 | Ignagni et al. | Jan 2005 | A1 |
20050027338 | Hill | Feb 2005 | A1 |
20050033136 | Govari et al. | Feb 2005 | A1 |
20050033137 | Oral et al. | Feb 2005 | A1 |
20050043765 | Williams et al. | Feb 2005 | A1 |
20050065567 | Lee et al. | Mar 2005 | A1 |
20050070981 | Verma | Mar 2005 | A1 |
20050075578 | Gharib et al. | Apr 2005 | A1 |
20050085865 | Tehrani | Apr 2005 | A1 |
20050085866 | Tehrani | Apr 2005 | A1 |
20050085867 | Tehrani et al. | Apr 2005 | A1 |
20050085868 | Tehrani et al. | Apr 2005 | A1 |
20050085869 | Tehrani et al. | Apr 2005 | A1 |
20050096710 | Kieval | May 2005 | A1 |
20050109340 | Tehrani | May 2005 | A1 |
20050113710 | Stahmann et al. | May 2005 | A1 |
20050115561 | Stahmann et al. | Jun 2005 | A1 |
20050131485 | Knudson et al. | Jun 2005 | A1 |
20050138791 | Black et al. | Jun 2005 | A1 |
20050138792 | Black et al. | Jun 2005 | A1 |
20050143787 | Boveja et al. | Jun 2005 | A1 |
20050165457 | Benser et al. | Jul 2005 | A1 |
20050182454 | Gharib et al. | Aug 2005 | A1 |
20050187584 | Denker et al. | Aug 2005 | A1 |
20050192655 | Black et al. | Sep 2005 | A1 |
20050251238 | Wallace et al. | Nov 2005 | A1 |
20050251239 | Wallace et al. | Nov 2005 | A1 |
20050288728 | Libbus et al. | Dec 2005 | A1 |
20050288730 | Deem et al. | Dec 2005 | A1 |
20060030894 | Tehrani | Feb 2006 | A1 |
20060035849 | Spiegelman et al. | Feb 2006 | A1 |
20060058852 | Koh et al. | Mar 2006 | A1 |
20060074449 | Denker et al. | Apr 2006 | A1 |
20060122661 | Mandell | Jun 2006 | A1 |
20060122662 | Tehrani et al. | Jun 2006 | A1 |
20060130833 | Younes | Jun 2006 | A1 |
20060142815 | Tehrani et al. | Jun 2006 | A1 |
20060149334 | Tehrani et al. | Jul 2006 | A1 |
20060155222 | Sherman et al. | Jul 2006 | A1 |
20060167523 | Tehrani et al. | Jul 2006 | A1 |
20060188325 | Dolan | Aug 2006 | A1 |
20060195159 | Bradley et al. | Aug 2006 | A1 |
20060217791 | Spinka et al. | Sep 2006 | A1 |
20060224209 | Meyer | Oct 2006 | A1 |
20060229677 | Moffitt et al. | Oct 2006 | A1 |
20060247729 | Tehrani et al. | Nov 2006 | A1 |
20060253161 | Libbus et al. | Nov 2006 | A1 |
20060253182 | King | Nov 2006 | A1 |
20060258667 | Teng | Nov 2006 | A1 |
20060259107 | Caparso et al. | Nov 2006 | A1 |
20060282131 | Caparso et al. | Dec 2006 | A1 |
20060287679 | Stone | Dec 2006 | A1 |
20070005053 | Dando | Jan 2007 | A1 |
20070021795 | Tehrani | Jan 2007 | A1 |
20070027448 | Paul et al. | Feb 2007 | A1 |
20070087314 | Gomo | Apr 2007 | A1 |
20070093875 | Chavan et al. | Apr 2007 | A1 |
20070106357 | Denker et al. | May 2007 | A1 |
20070112402 | Grill et al. | May 2007 | A1 |
20070112403 | Moffitt et al. | May 2007 | A1 |
20070118183 | Gelfand et al. | May 2007 | A1 |
20070150006 | Libbus et al. | Jun 2007 | A1 |
20070168007 | Kuzma et al. | Jul 2007 | A1 |
20070173900 | Siegel et al. | Jul 2007 | A1 |
20070191908 | Jacob et al. | Aug 2007 | A1 |
20070196780 | Ware et al. | Aug 2007 | A1 |
20070203549 | Demarais et al. | Aug 2007 | A1 |
20070208388 | Jahns et al. | Sep 2007 | A1 |
20070221224 | Pittman et al. | Sep 2007 | A1 |
20070240718 | Daly | Oct 2007 | A1 |
20070250056 | Vanney | Oct 2007 | A1 |
20070250162 | Royalty | Oct 2007 | A1 |
20070255379 | Williams et al. | Nov 2007 | A1 |
20070265611 | Ignagni et al. | Nov 2007 | A1 |
20070288076 | Bulkes et al. | Dec 2007 | A1 |
20080039916 | Colliou et al. | Feb 2008 | A1 |
20080065002 | Lobl et al. | Mar 2008 | A1 |
20080125828 | Ignagni et al. | May 2008 | A1 |
20080161878 | Tehrani et al. | Jul 2008 | A1 |
20080167695 | Tehrani et al. | Jul 2008 | A1 |
20080177347 | Tehrani et al. | Jul 2008 | A1 |
20080183186 | Bly et al. | Jul 2008 | A1 |
20080183187 | Bly | Jul 2008 | A1 |
20080183239 | Tehrani et al. | Jul 2008 | A1 |
20080183240 | Tehrani et al. | Jul 2008 | A1 |
20080183253 | Bly | Jul 2008 | A1 |
20080183254 | Bly et al. | Jul 2008 | A1 |
20080183255 | Bly et al. | Jul 2008 | A1 |
20080183259 | Bly et al. | Jul 2008 | A1 |
20080183264 | Bly et al. | Jul 2008 | A1 |
20080183265 | Bly et al. | Jul 2008 | A1 |
20080188903 | Tehrani et al. | Aug 2008 | A1 |
20080215106 | Lee et al. | Sep 2008 | A1 |
20080288010 | Tehrani et al. | Nov 2008 | A1 |
20080288015 | Tehrani et al. | Nov 2008 | A1 |
20080312712 | Penner | Dec 2008 | A1 |
20080312725 | Penner | Dec 2008 | A1 |
20090024047 | Shipley et al. | Jan 2009 | A1 |
20090036947 | Westlund et al. | Feb 2009 | A1 |
20090118785 | Ignagni et al. | May 2009 | A1 |
20090275956 | Burnes et al. | Nov 2009 | A1 |
20090275996 | Burnes et al. | Nov 2009 | A1 |
20090276022 | Burnes et al. | Nov 2009 | A1 |
20090318993 | Eidenschink | Dec 2009 | A1 |
20100022950 | Anderson et al. | Jan 2010 | A1 |
20100036451 | Hoffer | Feb 2010 | A1 |
20100077606 | Black et al. | Apr 2010 | A1 |
20100094376 | Penner | Apr 2010 | A1 |
20100114227 | Cholette | May 2010 | A1 |
20100114254 | Kornet | May 2010 | A1 |
20100198296 | Ignagni et al. | Aug 2010 | A1 |
20100204766 | Zdeblick et al. | Aug 2010 | A1 |
20100268311 | Cardinal et al. | Oct 2010 | A1 |
20100319691 | Lurie et al. | Dec 2010 | A1 |
20110060381 | Ignagni et al. | Mar 2011 | A1 |
20110077726 | Westlund et al. | Mar 2011 | A1 |
20110118815 | Kuzma et al. | May 2011 | A1 |
20110230932 | Tehrani et al. | Sep 2011 | A1 |
20110230935 | Zdeblick | Sep 2011 | A1 |
20110230945 | Ohtaka | Sep 2011 | A1 |
20110270358 | Davis et al. | Nov 2011 | A1 |
20110288609 | Tehrani et al. | Nov 2011 | A1 |
20120035684 | Thompson et al. | Feb 2012 | A1 |
20120053654 | Tehrani et al. | Mar 2012 | A1 |
20120078320 | Schotzko et al. | Mar 2012 | A1 |
20120130217 | Kauphusman et al. | May 2012 | A1 |
20120158091 | Tehrani et al. | Jun 2012 | A1 |
20120209284 | Westlund et al. | Aug 2012 | A1 |
20120215278 | Penner | Aug 2012 | A1 |
20120323293 | Tehrani et al. | Dec 2012 | A1 |
20130018247 | Glenn et al. | Jan 2013 | A1 |
20130018427 | Pham et al. | Jan 2013 | A1 |
20130023972 | Kuzma et al. | Jan 2013 | A1 |
20130030496 | Karamanoglu et al. | Jan 2013 | A1 |
20130030497 | Karamanoglu et al. | Jan 2013 | A1 |
20130030498 | Karamanoglu et al. | Jan 2013 | A1 |
20130060245 | Grunewald et al. | Mar 2013 | A1 |
20130116743 | Karamanoglu et al. | May 2013 | A1 |
20130123891 | Swanson | May 2013 | A1 |
20130131743 | Yamasaki et al. | May 2013 | A1 |
20130158625 | Gelfand et al. | Jun 2013 | A1 |
20130165989 | Gelfand et al. | Jun 2013 | A1 |
20130167372 | Black et al. | Jul 2013 | A1 |
20130197601 | Tehrani et al. | Aug 2013 | A1 |
20130237906 | Park et al. | Sep 2013 | A1 |
20130268018 | Brooke et al. | Oct 2013 | A1 |
20130289686 | Masson et al. | Oct 2013 | A1 |
20130296964 | Tehrani | Nov 2013 | A1 |
20130296973 | Tehrani et al. | Nov 2013 | A1 |
20130317587 | Barker | Nov 2013 | A1 |
20130333696 | Lee et al. | Dec 2013 | A1 |
20140067032 | Morris et al. | Mar 2014 | A1 |
20140088580 | Wittenberger et al. | Mar 2014 | A1 |
20140114371 | Westlund et al. | Apr 2014 | A1 |
20140121716 | Casavant et al. | May 2014 | A1 |
20140128953 | Zhao et al. | May 2014 | A1 |
20140148780 | Putz | May 2014 | A1 |
20140316486 | Zhou et al. | Oct 2014 | A1 |
20140324115 | Ziegler et al. | Oct 2014 | A1 |
20140378803 | Geistert et al. | Dec 2014 | A1 |
20150018839 | Morris et al. | Jan 2015 | A1 |
20150034081 | Tehrani et al. | Feb 2015 | A1 |
20150045848 | Cho et al. | Feb 2015 | A1 |
20150119950 | Demmer et al. | Apr 2015 | A1 |
20150165207 | Karamanoglu | Jun 2015 | A1 |
20150196354 | Haverkost et al. | Jul 2015 | A1 |
20150196356 | Kauphusman et al. | Jul 2015 | A1 |
20150231348 | Lee et al. | Aug 2015 | A1 |
20150250982 | Osypka et al. | Sep 2015 | A1 |
20150265833 | Meyyappan et al. | Sep 2015 | A1 |
20150283340 | Zhang et al. | Oct 2015 | A1 |
20150290476 | Krocak et al. | Oct 2015 | A1 |
20150359487 | Coulombe | Dec 2015 | A1 |
20150374252 | de la Rama et al. | Dec 2015 | A1 |
20150374991 | Morris et al. | Dec 2015 | A1 |
20160001072 | Gelfand et al. | Jan 2016 | A1 |
20160144078 | Young et al. | May 2016 | A1 |
20160193460 | Xu et al. | Jul 2016 | A1 |
20160228696 | Imran et al. | Aug 2016 | A1 |
20160239627 | Cerny et al. | Aug 2016 | A1 |
20160256692 | Baru | Sep 2016 | A1 |
20160310730 | Martins et al. | Oct 2016 | A1 |
20160331326 | Xiang et al. | Nov 2016 | A1 |
20160367815 | Hoffer | Dec 2016 | A1 |
20170007825 | Thakkar et al. | Jan 2017 | A1 |
20170013713 | Shah et al. | Jan 2017 | A1 |
20170021166 | Bauer et al. | Jan 2017 | A1 |
20170028191 | Mercanzini et al. | Feb 2017 | A1 |
20170036017 | Tehrani et al. | Feb 2017 | A1 |
20170050033 | Wechter | Feb 2017 | A1 |
20170143973 | Tehrani | May 2017 | A1 |
20170143975 | Hoffer et al. | May 2017 | A1 |
20170196503 | Narayan et al. | Jul 2017 | A1 |
20170224993 | Sathaye et al. | Aug 2017 | A1 |
20170232250 | Kim et al. | Aug 2017 | A1 |
20170252558 | O'Mahony et al. | Sep 2017 | A1 |
20170291023 | Kuzma et al. | Oct 2017 | A1 |
20170296812 | O'Mahony et al. | Oct 2017 | A1 |
20170312006 | McFarlin et al. | Nov 2017 | A1 |
20170312507 | Bauer et al. | Nov 2017 | A1 |
20170312508 | Bauer et al. | Nov 2017 | A1 |
20170312509 | Bauer et al. | Nov 2017 | A1 |
20170326359 | Gelfand et al. | Nov 2017 | A1 |
20170347921 | Haber et al. | Dec 2017 | A1 |
20180001086 | Bartholomew et al. | Jan 2018 | A1 |
20180008821 | Gonzalez et al. | Jan 2018 | A1 |
20180110562 | Govari et al. | Apr 2018 | A1 |
20180117334 | Jung | May 2018 | A1 |
Number | Date | Country |
---|---|---|
1652839 | Aug 2005 | CN |
102143781 | Aug 2011 | CN |
0993840 | Apr 2000 | EP |
1304135 | Apr 2003 | EP |
0605796 | Aug 2003 | EP |
2489395 | Aug 2012 | EP |
2801509 | Jun 2001 | FR |
08-510677 | Nov 1996 | JP |
2003-503119 | Jan 2003 | JP |
2010516353 | May 2010 | JP |
2011-200571 | Oct 2011 | JP |
2012000195 | Jan 2012 | JP |
2012-000195 | Jan 2012 | JP |
9407564 | Apr 1994 | WO |
WO 9508357 | Mar 1995 | WO |
9964105 | Dec 1999 | WO |
9965561 | Dec 1999 | WO |
0100273 | Jan 2001 | WO |
02058785 | Aug 2002 | WO |
WO 03094855 | Nov 2003 | WO |
2006110338 | Oct 2006 | WO |
2006115877 | Nov 2006 | WO |
2007053508 | May 2007 | WO |
2008092246 | Aug 2008 | WO |
2008094344 | Aug 2008 | WO |
2009006337 | Jan 2009 | WO |
2009134459 | Nov 2009 | WO |
WO 2010029842 | Mar 2010 | WO |
WO 2011158410 | Jun 2010 | WO |
2010148412 | Dec 2010 | WO |
2012106533 | Aug 2012 | WO |
2013131187 | Sep 2013 | WO |
2013188965 | Dec 2013 | WO |
Entry |
---|
Pavlovic, D. et al, “Diaphragm pacing during prolonged mechanical ventilation of the lungs could prevent from respiratory muscle fatigue”, Medical Hypotheses, 2003, vol. 60, No. 3, pp. 398-403. |
Search Report—Patent Office of the People's Republic of China, dated Jul. 24, 2015, in corresponding Application No. CN 2013/80023357.5. |
Search Report—European Patent Office, dated Nov. 12, 2015, in corresponding Application No. EP 13758363. |
Levine, et al., New England Journal of Medicine, 358: 1327-1335, 2008. |
De Gregorio, M.A. et al., “The Gunther Tulip Retrievable Filter: Prolonged Temporary Filtration by Repositioning within the Inferior Vena Cava”, J Vasc Interv Radiol, 14:1259-1265, 2003. |
Onders, R. et al., “Diaphragm pacing with natural orifice transluminal endoscopic surgery: potential for difficult-to-wean intensive care unit patients”, Surg Endosc, 21:475-479, 2007. |
Sarnoff, S.J. et al., “Electrophrenic Respiration”, Science, 108:482, 1948. |
Marcy, T.W. et al., “Diaphragm Pacing for Ventilatory Insufficiency”, Journal of Intensive Care Medicine, vol. 2, No. 6, pp. 345-353, 1987. |
Hoffer, J.A. et al., Diaphragm Pacing with Endovascular Electrodes, Sep. 2010. |
Daggett, W.M. et al., “Intracaval electrophrenic stimulation. I. Experimental Application During Barbiturate Intoxication Hemorrhage and Gang”, Journal of Thoracic and Cardiovascular Surgery,51(5):676-884, 1966. |
Furman, S., “Transvenous Stimulation of the Phrenic Nerves”, Journal of Thoracic and Cardiovascular Surgery, 62 (5):743-751, 1971. |
Wanner, A. et al., “Trasvenous phrenic nerve stimulation in anesthetized dogs”, Journal of Applied Physiology, 34 (4):489-494, 1973. |
Daggett, W.M. et al., “Intracaval electrophrenic stimulation. II. Studies on Pulmonary Mechanics Surface Tension Urine Flow and Bilateral Ph”, Journal of Thoracic and Cardiovascular Surgery, 60(1):98-107, 1970. |
Japanese Office Action in corresponding Japanese Application No. 2014-560202, dated Dec. 6, 2016 (4 pages). |
European Search Report dated Sep. 8, 2017 in corresponding European Patent Application No. 17169051.4 (7pages). |
Japanese Office Action dated Oct. 17, 2017 in corresponding Japanese Patent Application No. 2014-560202 (5 pages). |
Escher, Doris J.W. et al., “Clinical Control of Respiration by Transvenous Phrenic Pacing,” American Society for Artificial Internal Organs: Apr. 1968—vol. 14—Issue 1—pp. 192-197. |
Ishii, K. et al., “Effects of Bilateral Transvenous Diaphragm Pacing on Hemodynamic Function in Patients after Cardiac Operations,” J. Thorac. Cardiovasc. Surg., 1990. |
Antonica A., et al., “Vagal Control of Lymphocyte Release from Rat Thymus,” Journal of the Autonomic Nervous System, Elsevier, vol. 48(3), Aug. 1994, pp. 187-197. |
Ryas N.T., et al., “Prevention of Human Diaphragm Atrophy with Short periods of Electrical Stimulation,” American Journal of Respiratory and Critical Care Medicine, Jun. 1999, vol. 159(6), pp. 2018-2020. |
Borovikova, et al., “Role of the Vagus Nerve in the Anti-Inflammatory Effects of CNI-1493,” Proceedings of the Annual Meeting of Professional Research Scientists: Experimental Biology 2000, Abstract 97.9, Apr. 15-18, 2000. |
Borovikovaa L.V., et al., “Role of Vagus Nerve Signaling in CNI-1493-Mediated Suppression of Acute Inflammation,” Autonomic Neuroscience: Basic and Clinical, vol. 85 (1-3), Dec. 20, 2000, pp. 141-147. |
Borovikovaa L.V., et al., “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin,” Nature, Macmillan Magazines Ltd, vol. 405, May 25, 2000, pp. 458-462. |
Co-pending U.S. Appl. No. 15/606,867, filed May 26, 2017. |
Deng Y-J et al., “The Effect of Positive Pressure Ventilation Combined with Diaphragm Pacing on Respiratory Mechanics in Patients with Respiratory Failure; Respiratory Mechanics,” Chinese critical care medicine, Apr. 2011, vol. 23(4), pp. 213-215. |
Extended European Search Report for Application No. 14864542.7, dated Jun. 2, 2017, 8 pages. |
Extended European Search Report for Application No. 15740415.3, dated Jul. 7, 2017. |
Fleshner M., et al., “Thermogenic and Corticosterone Responses to Intravenous Cytokines (IL-1β and TNF-α) are Attenuated by Subdiaphragmatic Vagotomy,” Journal of Neuroimmunology, vol. 86, Jun. 1998, pp. 134-141. |
Frisch S., “A Feasibility Study of a Novel Minimally Invasive Approach for Diaphragm Pacing,” Master of Science Thesis, Simon Fraser University, 2009, p. 148. |
Gaykema R.P.A. et al., “Subdiaphragmatic Vagotomy Suppresses Endotoxin-Induced Activation of Hypothalamic Corticotropin-Releasing Hormone Neurons and ACTH Secretion,” Endocrinology, The Endocrine Society, vol. 136 (10), 1995, pp. 4717-4720. |
Gupta A.K., “Respiration Rate Measurement Based on Impedance Pneumography,” Data Acquisition Products, Texas Instruments, Application Report, SBAA181, Feb. 2011, 11 pages. |
Guslandi M., “Nicotine Treatment for Ulcerative Colitis,” The British Journal of Clinical Pharmacology, Blackwell Science Ltd, vol. 48, 1999, pp. 481-484. |
Kawashima K., et al., “Extraneuronal Cholinergic System in Lymphocytes,” Pharmacology & Therapeutics, Elsevier, vol. 86, 2000, pp. 29-48. |
Lungpacer: Therapy, News . . . Accessed Dec. 27, 2016. |
Madretsma, G.S., et al., “Nicotine Inhibits the In-vitro Production of Interleukin 2 and Tumour Necrosis Factor-α by Human Mononuclear Cells,” Immunopharmacology, Elsevier, vol. 35 (1), Oct. 1996, pp. 47-51. |
Meyyappan R., “Diaphragm Pacing during Controlled Mechanical Ventilation: Pre-Clinical Observations Reveal a Substantial Improvement in Respiratory Mechanics”, 17th Biennial Canadian Biomechanics Society Meeting, Bumaby, BC, Jun. 6-9, 2012. |
Nabutovsky, Y., et al., “Lead Design and Initial Applications of a New Lead for Long-Term Endovascular Vagal Stimulation,” PACE, Blackwell Publishing, Inc, vol. 30(1), Jan. 2007, pp. 5215-S218. |
Notification of Reasons for Rejection and English language translation issued in corresponding Japanese Patent Application No. 2015-517565, dated Mar. 28, 2017, 6 pages. |
Onders R.,, “A Diaphragm Pacing as a Short-Term Assist to Positive Pressure Mechanical Ventilation in Critical Care Patients,” Chest, Oct. 24, 2007, vol. 132(4), pp. 5715-5728. |
Onders R.,, “Diaphragm Pacing for Acute Respiratory Failure,” Difficult Decisions in Thoracic Surgery, Chapter 37, Springer-Verlag, 2011, M.K. Ferguson (ed.), pp. 329-335. |
Planas R.F., et al., “Diaphragmatic Pressures: Transvenous vs. Direct Phrenic Nerve Stimulation,” Journal of Applied Physiology, vol. 59(1), 1985, pp. 269-273. |
Romanovsky, A.A., et al., “The Vagus Nerve in the Thermoregulatory Response to Systemic Inflammation,” American Journal of Physiology, vol. 273 (1 Pt 2), 1997, pp. R407-R413. |
Salmela L., et al., “Verification of the Position of a Central Venous Catheter by Intra-Atrial ECG. When does this method fail?,” Acta Anasthesiol Scand, vol. 37 (1), 1993, pp. 26-28. |
Sandborn W.J., “Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis,” Annals of Internal Medicine, vol. 126 (5), Mar. 1, 1997, pp. 364-371. |
Sandoval R., “A Catch/Ike Property-Based Stimulation Protocol for Diaphragm Pacing”, Master of Science Coursework project, Simon Fraser University, Mar. 2013. |
Sato E., et al., “Acetylcholine Stimulates Alveolar Macrophages to Release Inflammatory Cell Chemotactic Activity,” American Journal of Physiology, vol. 274 (Lung Cellular and Molecular Physiology 18), 1998, pp. L970-L979. |
Sato, K.Z., et al., “Diversity of mRNA Expression for Muscarinic Acetylcholine Receptor Subtypes and Neuronal Nicotinic Acetylcholine Receptor Subunits in Human Mononuclear Leukocytes and Leukemic Cell Lines,” Neuroscience Letters, vol. 266 (1), 1999, pp. 17-20. |
Schauerte P., et al., “Transvenous Parasympathetic Nerve Stimulation in the Inferior Vena Cava and Atrioventricular Conduction,” Journal of Cardiovascular Electrophysiology, vol. 11 (1), Jan. 2000, pp. 64-69. |
Schauerte P.N., et al., “Transvenous Parasympathetic Cardiac Nerve Stimulation: An Approach for Stable Sinus Rate Control,” Journal of Cardiovascular Electrophysiology, vol. 10 (11), Nov. 1999, pp. 1517-1524. |
Scheinman R.I., et al., “Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids,” Science, vol. 270, Oct. 13, 1995, pp. 283-286. |
Sher, M.E, et al., “The Influence of Cigarette Smoking on Cytokine Levels in Patients with Inflammatory Bowel Disease,” Inflammatory Bowel Diseases, vol. 5 (2), May 1999, pp. 73-78. |
Steinlein, O., “New Functions for Nicotinic Acetylcholine Receptors?,” Behavioural Brain Research, vol. 95, 1998, pp. 31-35. |
Sternberg E.M., (Series Editor) “Neural-Immune Interactions in Health and Disease,” The Journal of Clinical Investigation, vol. 100 (11), Dec. 1997, pp. 2641-2647. |
Sykes., A.P., et al., “An Investigation into the Effect and Mechanisms of Action of Nicotine in Inflammatory Bowel Disease,” Inflammation Research, vol. 49, 2000, pp. 311-319. |
Toyabe S., et al., “Identification of Nicotinic Acetylcholine Receptors on Lymphocytes in the Periphery as well as Thymus in Mice,” Immunology, vol. 92, 1997, pp. 201-205. |
Van Dijk A.P.M., et al., “Transdermal Nicotine Inhibits Interleukin 2 Synthesis by Mononuclear Cells Derived from Healthy Volunteers,” European Journal of Clinical Investigation, vol. 28, 1998, pp. 664-671. |
Watkins L.R., et al., “Blockade of Interleukin-1 Induced Hyperthermia by Subdiaphragmatic Vagotomy: Evidence for Vagal Mediation of Immune-Brain Communication,” Neuroscience Letters, vol. 183, 1995, pp. 27-31. |
Watkins L.R., et al., “Implications of Immune-to-Brain Communication for Sickness and Pain,” PNAS (Proceedings of the National Academy of Sciences of the USA), vol. 96 (14), Jul. 6, 1999, pp. 7710-7713. |
Whaley K, et al., “C2 Synthesis by Human Monocytes is Modulated by a Nicotinic Cholinergic Receptor,” Nature, vol. 293, Oct. 15, 1981, pp. 580-582 (and reference page). |
Number | Date | Country | |
---|---|---|---|
20150045810 A1 | Feb 2015 | US |
Number | Date | Country | |
---|---|---|---|
61606899 | Mar 2012 | US |